The Impact of Hyperoxia in the Critically Ill Patient: A Review of the Literature

2020 ◽  
Vol 65 (8) ◽  
pp. 1202-1210 ◽  
Author(s):  
Jacob Martin ◽  
Maryann Mazer-Amirshahi ◽  
Ali Pourmand
Keyword(s):  
Critically Ill ◽  
Critically Ill Patient ◽  
Review Of The Literature ◽  
The Impact

Noninvasive Ventilation in the Critically Ill Patient With Obesity Hypoventilation Syndrome: A Review

2016 ◽  
Vol 32 (7) ◽  
pp. 421-428 ◽  
Author(s):  
Telma C. A. Sequeira ◽  
Ahmed S. BaHammam ◽  
Antonio M. Esquinas
Keyword(s):  
Respiratory Failure ◽  
Critically Ill ◽  
Noninvasive Ventilation ◽  
Hospital Admissions ◽  
Lung Mechanics ◽  
Critically Ill Patient ◽  
Obesity Hypoventilation Syndrome ◽  
Hypoventilation Syndrome ◽  
The Impact ◽  
Obesity Hypoventilation

Obesity is a global epidemic that adversely affects respiratory physiology. Sleep-disordered breathing and obesity hypoventilation syndrome (OHS) are among the most common pulmonary complications related to obesity class III. Patients with OHS may present with acute hypercapnic respiratory failure (AHRF) that necessitates immediate noninvasive ventilation (NIV) or invasive ventilation and intensive care unit (ICU) monitoring. The OHS is underrecognized as a cause of AHRF. The management of mechanical ventilation in obese ICU patients is one of the most challenging problems facing respirologists, intensivists, and anesthesiologists. The treatment of AHRF in patients with OHS should aim to improve alveolar ventilation with better alveolar gas exchange, as well as maintaining a patent upper airway, which is ideally achieved through NIV. Treatment with NIV is associated with improvement in blood gases and lung mechanics and may reduce hospital admissions and morbidity. In this review, we will address 3 main issues: (1) NIV of critically ill patients with acute respiratory failure and OHS; (2) the indications for postoperative application of NIV in patients with OHS; and (3) the impact of OHS on weaning and postextubation respiratory failure. Additionally, the authors propose an algorithm for the management of obese patients with AHRF.

Pleural Disease in the Intensive Care Unit

2000 ◽  
Vol 15 (2) ◽  
pp. 63-89
Author(s):  
Michael A. Jantz ◽  
Steven A. Sahn
Keyword(s):  
Intensive Care Unit ◽  
Intensive Care ◽  
Pleural Effusion ◽  
Critically Ill ◽  
Bronchopleural Fistula ◽  
Tension Pneumothorax ◽  
Respiratory Physiology ◽  
Critically Ill Patient ◽  
Pleural Disease ◽  
The Impact

Pleural disease itself is an unusual cause for admission to the intensive care unit (ICU). Pleural complications of diseases and procedures in the ICU are common, however, and the impact on respiratory physiology is additive to that of the underlying cardiopulmonary disease. Pleural effusion and pneumothorax may be overlooked in the critically ill patient due to alterations in radiologic appearance in the supine patient. The development of a pneumothorax in a patient in the ICU represents a potentially life-threatening situation. This article reviews the etiologies, pathophysiology, and management of pleural effusion, pneumothorax, tension pneumothorax, and bronchopleural fistula in the critically ill patient. In addition, we review the potential complications of thoracentesis and chest tube thoracostomy, including re-expansion pulmonary edema.

Advances and Controversies in Adult ICU Sedation, Part 1: An Overview of the Importance of Sedation and Agitation and Subjective Assessment Tools for Patient Evaluation

2001 ◽  
Vol 36 (12) ◽  
pp. 1266-1278
Author(s):  
Gilles L. Fraser ◽  
Richard Riker
Keyword(s):  
Health Care ◽  
Drug Therapy ◽  
Critically Ill ◽  
Subjective Assessment ◽  
Assessment Tools ◽  
Critically Ill Patient ◽  
Patient Evaluation ◽  
Icu Patients ◽  
Icu Sedation ◽  
The Impact

This feature examines the impact of pharmacologic interventions on the treatment of the critically ill patient—an area of health care that has become increasingly complex. It will review recent advances (including evolving and controversial data) in drug therapy for adult ICU patients and assess these new modalities in terms of clinical, humanistic, and economic outcomes. Direct questions or comments to Gil Fraser, PharmD, at [email protected] .

Corticosteroids in ARDS: The Never-Ending Story

2007 ◽  
Vol 42 (8) ◽  
pp. 691-701 ◽  
Author(s):  
Zachariah Thomas ◽  
Katarzyna Kimborowicz
Keyword(s):  
Health Care ◽  
Intensive Care Unit ◽  
Intensive Care ◽  
Drug Therapy ◽  
Critically Ill ◽  
Economic Outcomes ◽  
Critically Ill Patient ◽  
Adult Intensive Care Unit ◽  
Recent Advances ◽  
The Impact

This feature examines the impact of pharmacologic interventions on the treatment of the critically ill patient — an area of health care that has become increasingly complex. Recent advances in drug therapy (including evolving and controversial data) for adult intensive-care-unit patients will be reviewed and assessed in terms of clinical, humanistic, and economic outcomes.

Behavioral Effects of ICU Medications

2005 ◽  
Vol 40 (5) ◽  
pp. 387-392
Author(s):  
Gil Fraser ◽  
Richard R. Riker
Keyword(s):  
Health Care ◽  
Drug Therapy ◽  
Critically Ill ◽  
Economic Outcomes ◽  
Behavioral Effects ◽  
Critically Ill Patient ◽  
Icu Patients ◽  
Recent Advances ◽  
The Impact

This feature examines the impact of pharmacologic interventions on the treatment of the critically ill patient — an area of health care that has become increasingly complex. Recent advances in drug therapy for adult ICU patients (including evolving and controversial data) will be reviewed and assessed in terms of clinical, humanistic, and economic outcomes. Direct questions or comments to Gil Fraser, PharmD, at [email protected] .

Early Treatment with Fluconazole in Adult ICU Patients at High Risk for Severe Candidiasis

2002 ◽  
Vol 37 (9) ◽  
pp. 928-935 ◽  
Author(s):  
Jason A. Yahwak ◽  
Gilles L. Fraser
Keyword(s):  
Health Care ◽  
Drug Therapy ◽  
High Risk ◽  
Critically Ill ◽  
Early Treatment ◽  
Economic Outcomes ◽  
Critically Ill Patient ◽  
Icu Patients ◽  
Recent Advances ◽  
The Impact

This feature examines the impact of pharmacologic interventions on the treatment of the critically ill patient–an area of health care that has become increasingly complex. It will review recent advances (including evolving and controversial data) in drug therapy for adult ICU patients and assess these new modalities in terms of clinical, humanistic, and economic outcomes.

Important Changes in the ACLS 2000 Guidelines for the Management of Cardiac Arrest

2002 ◽  
Vol 37 (5) ◽  
pp. 469-473 ◽  
Author(s):  
Gilles L. Fraser ◽  
Sandra P. Bagwell
Keyword(s):  
Health Care ◽  
Cardiac Arrest ◽  
Drug Therapy ◽  
Critically Ill ◽  
Economic Outcomes ◽  
Critically Ill Patient ◽  
Icu Patients ◽  
Recent Advances ◽  
The Impact

This feature examines the impact of pharmacologic interventions on the treatment of the critically ill patient—an area of health care that has become increasingly complex. It will review recent advances (including evolving and controversial data) in drug therapy for adult ICU patients and assess these new modalities in terms of clinical, humanistic, and economic outcomes.

Sign in / Sign up

Export Citation Format

Share Document